{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:08:16Z","timestamp":1777374496860,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016244","name":"Health Foundation Limburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016244","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003195","name":"Ministerie van Economische Zaken","doi-asserted-by":"publisher","award":["31O.041"],"award-info":[{"award-number":["31O.041"]}],"id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011095","name":"Care and Public Health Research Institute, Universiteit Maastricht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019392","name":"NUTRIM School of Nutrition and Translational Research in Metabolism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011097","name":"CARIM School for Cardiovascular Diseases, Universiteit Maastricht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032165","name":"Janssen Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009709","name":"Stichting De Weijerhorst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004529","name":"Stichting Sint Annadal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004529","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jns.2025.123522","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:41:44Z","timestamp":1746499304000},"page":"123522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The kynurenine pathway and markers of neurodegeneration and cerebral small vessel disease: The Maastricht Study"],"prefix":"10.1016","volume":"474","author":[{"given":"Lieke","family":"Bakker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inez H.G.B.","family":"Ramakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen M.J.","family":"van Greevenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter H.","family":"Backes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus F.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda T.","family":"Schram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla J.H.","family":"van der Kallen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper G.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Wesselius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arve","family":"Ulvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per M.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans R.J.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone J.P.M.","family":"Eussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123522_bb0005","author":"Nederland"},{"key":"10.1016\/j.jns.2025.123522_bb0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fneur.2020.00927","article-title":"Cerebral small vessel disease and Alzheimer\u2019s disease: a review","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.123522_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.17219\/acem\/131216","article-title":"Cerebral small vessel disease: a review","volume":"30","author":"Chojdak-Lukasiewicz","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.jns.2025.123522_bb0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2019.00778","article-title":"Systematic review on the involvement of the kynurenine pathway in stroke: pre-clinical and clinical evidence","volume":"10","author":"Colpo","year":"2019","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2025.123522_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14728222.2018.1524877","article-title":"Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer\u2019s disease","volume":"22","author":"Sharma","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jns.2025.123522_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res"},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123522_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schrocksnadel","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jns.2025.123522_bb0045","article-title":"Dynamic changes in metabolites of the kynurenine pathway in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: a systematic review and meta-analysis","volume":"13","author":"Fathi","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-019-1567-4","article-title":"Plasma neurofilament light chain and amyloid-beta are associated with the kynurenine pathway metabolites in preclinical Alzheimer\u2019s disease","volume":"16","author":"Chatterjee","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2025.123522_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S13958","article-title":"Kynurenic acid levels in cerebrospinal fluid from patients with Alzheimer\u2019s disease or dementia with lewy bodies","volume":"7","author":"Wennstrom","year":"2014","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.jns.2025.123522_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-beta and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2025.123522_bb0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbi.2023.04.015","article-title":"Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer\u2019s disease pathology","volume":"111","author":"Bakker","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer\u2019s disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Rep."},{"issue":"7","key":"10.1016\/j.jns.2025.123522_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2025.123522_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jad.2019.08.034","article-title":"Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder","volume":"259","author":"Poletti","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.jns.2025.123522_bb0090","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jns.2025.123522_bb0095","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jad.2017.11.040","article-title":"A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls","volume":"227","author":"DeWitt","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00406-016-0731-4","article-title":"Kynurenine pathway and white matter microstructure in bipolar disorder","volume":"268","author":"Poletti","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jns.2025.123522_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and Amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2025.123522_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jns.2025.123522_bb0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2025.123522_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2022.07.011","article-title":"C-reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder","volume":"105","author":"Zheng","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2478\/v10039-010-0015-6","article-title":"Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients","volume":"55","author":"Pawlak","year":"2010","journal-title":"Adv. Med. Sci."},{"issue":"3","key":"10.1016\/j.jns.2025.123522_bb0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCRESAHA.114.302113","article-title":"Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.jns.2025.123522_bb0140","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00125-021-05521-4","article-title":"Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the Maastricht study","volume":"64","author":"Bakker","year":"2021","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.jns.2025.123522_bb0145","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2337\/dc18-1132","article-title":"Prediabetes is associated with structural brain abnormalities: the Maastricht study","volume":"41","author":"van Agtmaal","year":"2018","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jns.2025.123522_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-014-9889-0","article-title":"The Maastricht study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities","volume":"29","author":"Schram","year":"2014","journal-title":"Eur. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1373\/clinchem.2011.174490","article-title":"Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism","volume":"58","author":"Hustad","year":"2012","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.jns.2025.123522_bb0160","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","article-title":"Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Midttun","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1148\/radiol.2021202634","article-title":"Interplay of white matter Hyperintensities, cerebral networks, and cognitive function in an adult population: diffusion-tensor imaging in the Maastricht study","volume":"298","author":"Vergoossen","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuroimage.2007.05.018","article-title":"Multi-spectral brain tissue segmentation using automatically trained k-nearest-neighbor classification","volume":"37","author":"Vrooman","year":"2007","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0175","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.neuroimage.2009.01.011","article-title":"White matter lesion extension to automatic brain tissue segmentation on MRI","volume":"45","author":"de Boer","year":"2009","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/STROKEAHA.108.526996","article-title":"Improving interrater agreement about brain microbleeds: development of the brain observer MicroBleed scale (BOMBS)","volume":"40","author":"Cordonnier","year":"2009","journal-title":"Stroke"},{"issue":"21","key":"10.1016\/j.jns.2025.123522_bb0185","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","article-title":"The Microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds","volume":"73","author":"Gregoire","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2025.123522_bb0190","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1249\/01.MSS.0000084419.64044.2B","article-title":"Validity of a modified CHAMPS physical activity questionnaire among African-Americans","volume":"35","author":"Resnicow","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"issue":"Suppl. 20","key":"10.1016\/j.jns.2025.123522_bb0195","first-page":"22","article-title":"The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jns.2025.123522_bb0200","series-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO\/IDF Consultation","author":"Organization, W.H","year":"2006"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jns.2025.123522_bb0210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines","volume":"8","author":"Durrleman","year":"1989","journal-title":"Stat. Med."},{"key":"10.1016\/j.jns.2025.123522_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120819","article-title":"The role of the kynurenine pathway in cognitive functioning after stroke: a prospective clinical study","volume":"454","author":"Bakker","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2025.123522_bb0220","article-title":"Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases","volume":"2014","author":"Ocampo","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0225","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.jns.2025.123522_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: Anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int J Tryptophan Res"},{"issue":"6349","key":"10.1016\/j.jns.2025.123522_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0245","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-220295","article-title":"The tryptophan catabolite or kynurenine pathway in Alzheimer\u2019s disease: a systematic review and Meta-analysis","volume":"88","author":"Almulla","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in Alzheimer\u2019s disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2025.123522_bb0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","article-title":"Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder","volume":"52","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","article-title":"Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington\u2019s disease","volume":"112","author":"Forrest","year":"2010","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.jns.2025.123522_bb0265","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","article-title":"Altered kynurenine metabolism correlates with infarct volume in stroke","volume":"26","author":"Darlington","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jns.2025.123522_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2015.08.1371","article-title":"Alterations of tryptophan metabolites in cerebrospinal fluid and serum after stroke","volume":"357","author":"Kepplinger","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.jns.2025.123522_bb0280","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jalz.2017.04.009","article-title":"Association of amine biomarkers with incident dementia and Alzheimer\u2019s disease in the Framingham study","volume":"13","author":"Chouraki","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"issue":"2","key":"10.1016\/j.jns.2025.123522_bb0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer\u2019s disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biopha.2009.07.002","article-title":"Antioxidant activity of tryptophan in rats under experimental endotoxic shock","volume":"64","author":"Bitzer-Quintero","year":"2010","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1515\/pteridines.2002.13.4.140","article-title":"Tryptophan metabolites as scavengers of reactive oxygen and chlorine species","volume":"13","author":"Weiss","year":"2002","journal-title":"Pteridines"},{"issue":"26","key":"10.1016\/j.jns.2025.123522_bb0300","doi-asserted-by":"crossref","first-page":"10215","DOI":"10.1021\/jf062134n","article-title":"Amino acid and protein scavenging of radicals generated by iron\/hydroperoxide system: an electron spin resonance spin trapping study","volume":"54","author":"Pazos","year":"2006","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.jns.2025.123522_bb0305","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/npp.2016.66","article-title":"Tryptophan metabolism and white matter integrity in schizophrenia","volume":"41","author":"Chiappelli","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.66.1.100","article-title":"Decreased plasma tryptophan associated with deep white matter lesions in elderly subjects","volume":"66","author":"Yao","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0315","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.18632\/aging.101837","article-title":"Longitudinal plasma metabolomics of aging and sex","volume":"11","author":"Darst","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jns.2025.123522_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5019752","article-title":"Kynurenine pathway metabolites in the blood and cerebrospinal fluid are associated with human aging","volume":"2022","author":"Solvang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jns.2025.123522_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2017.01561","article-title":"The relationships among tryptophan, kynurenine, Indoleamine 2,3-dioxygenase, depression, and neuropsychological performance","volume":"8","author":"Hestad","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jns.2025.123522_bb0330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2017.08.024","article-title":"Kynurenic acid is reduced in females and oral contraceptive users: implications for depression","volume":"67","author":"Meier","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2025.123522_bb0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/IJTR.S38189","article-title":"Assessment of the human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion","volume":"9","author":"Badawy","year":"2016","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"10.1016\/j.jns.2025.123522_bb0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.12092","article-title":"A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland health study","volume":"173","author":"Theofylaktopoulou","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jns.2025.123522_bb0345","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3945\/jn.114.203091","article-title":"Tryptophan catabolism and vitamin B-6 status are affected by gender and lifestyle factors in healthy young adults\u20133","volume":"145","author":"Deac","year":"2015","journal-title":"J. Nutr."},{"issue":"9","key":"10.1016\/j.jns.2025.123522_bb0350","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11064-010-0187-2","article-title":"The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke","volume":"35","author":"Brouns","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jns.2025.123522_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.jns.2025.123522_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716980","article-title":"Brain versus blood: a systematic review on the concordance between peripheral and central kynurenine pathway measures in psychiatric disorders","volume":"12","author":"Skorobogatov","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2500139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2500139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:51:16Z","timestamp":1762210276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2500139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":72,"alternative-id":["S0022510X2500139X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123522","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kynurenine pathway and markers of neurodegeneration and cerebral small vessel disease: The Maastricht Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123522"}}